Information  X 
Enter a valid email address

James Halstead PLC (JHD)

  Print      Mail a friend       Annual reports

Thursday 30 January, 2020

James Halstead PLC

Trading Update

RNS Number : 2855B
James Halstead PLC
30 January 2020
 

 

 

30 January 2020

 

JAMES HALSTEAD PLC

Trading Update


James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update ahead of its interim results for the half-year to 31 December 2019.

 

In his AGM statement, on 6 December 2019, the Chairman, Mr. Anthony Wild, noted that trading to date had been encouraging in terms of turnover and profit for the first five months of the current financial year. This trend continued into December and, once again, the company expects to attain record turnover for the half-year. The projects supplied continue to span the globe with interesting examples such as the Hobbiton tourist resort in New Zealand and Agent Provocateur in London together with the ubiquitous supply of flooring to the NHS such as Chelsea & Westminster Hospital and Hull Royal Infirmary.

 

Turnover in the UK was 6.8% ahead of the prior year, a creditable performance against the prevailing market conditions. Underlying margins held up but in the period July through to September there were adverse manufacturing variances and incremental labour costs associated with extended shifts / overtime subsequent to a significant engineering breakdown. Notwithstanding this adversity the company expects to report record pre-tax profit for the half-year.

 

Our balance sheet remains robust.

 

Interim results will be published on 31 March 2020.

 

Enquiries:




James Halstead plc

Tel: 0161 767 2500

Mark Halstead, Chief Executive


Gordon Oliver, Finance Director




Hudson Sandler

Tel: 020 7796 4133

Nick Lyon /Nick Moore




Panmure Gordon (Nomad and Joint Broker)

Tel: 020 7886 2500

Dominic Morley




Arden Partners (Joint Broker)        

Richard Johnson

 

Tel: 020 7614 5900

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TSTKKCBBCBKKKDB

a d v e r t i s e m e n t